Papers & Letters

Submission to FDA: Framing issues in evaluating a Modified Risk Tobacco Product application

November 2014: United States / FDA
Letter
My views on the many absurdities of the way the US regulator, the FDA, approaches…

WHO position on ENDS (e-cigarettes): A critique of the use of science and communication of risk

October 2014: Global / WHO
Letter
Analysis of the false and misleading risk communications about e-cigarettes coming from WHO in the…

Brief for House of Commons of Canada Standing Committee on Health

October 2014: Canada
Briefing
A disruptive public health technology threatened by excessive regulation. See blog: Canadian Dawn – following a positive…

Critical commentary on the public comments on the FDA deeming rule submitted by UCSF faculty and fellows

August 2014: United States / FDA
Letter
My critique of the multiple submissions to the FDA by Professor Stanton Glantz and his…

Letter to WHO Director General Margaret Chan by 53 scientists and experts

May 2014: Global / WHO
Letter
Reducing the toll of death and disease from tobacco – tobacco harm reduction and the…
Scroll to Top